Objectives HIV‐related pulmonary arterial hypertension (PAH) is a rare entity but is
associated with significant morbidity and mortality. The literature describing the outcomes of …

Pulmonary arterial hypertension (PAH) is a life‐threatening complication of HIV infection.
The prevalence of HIV‐associated PAH (HIV‐PAH) seems not to be changed over time …

AIM: To present 18 new cases of human immunodeficiency virus (HIV)-related pulmonary
arterial hypertension (PAH) with presenting features, treatment options and follow-up data …

Pulmonary arterial hypertension (PAH) is a rare but severe disease that results from chronic
obstruction of small pulmonary arteries, leading to right ventricular failure and, ultimately …

Pulmonary arterial hypertension (PAH) is a life-threatening complication of HIV infection.
The prevalence of HIV-associated PAH (HIV-PAH) seems not to be changed over time …

Modern treatment with antiretroviral therapy (ART) has improved survival for patients with
human immunodeficiency virus (HIV) infection. Cardiovascular disease and other non-AIDS …

Background Idiopathic pulmonary arterial hypertension (PAH) is a rare disease. HIV‐
infected patients exhibit a considerably higher rate of development of this condition …

Pulmonary arterial hypertension (PAH) is a rare but life-threatening complication of human
immunodeficiency virus (HIV) infection. PAH can complicate the course of HIV infection …

The success of antiretroviral therapies in improving the survival of patients infected with HIV
and reducing HIV-associated opportunistic infections is undisputed. Nevertheless, long-term …

There has been substantial progress in our understanding of the pathogenesis and clinical
consequences of infection with HIV since the virus was first identified more than 20 years …